AGITG 2013* , ,
Presentations this author is a contributor to:
A PHASE IB STUDY OF SECOND-LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN METASTATIC COLORECTAL CANCER (mCRC) WITH KRAS WILD TYPE (WT) (#22)
12:45 PM
Amanda Townsend
Poster Review
Circulating tumour DNA (ctDNA) in patients with metastatic colorectal cancer (mCRC): Prognostic significance and early changes during chemotherapy (#21)
12:45 PM
Jeanne Tie
Poster Review
Indigenous patients and metastatic colorectal cancer: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry (#6)
12:45 PM
Christopher Hocking
Poster Review